Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Steger

Showing results (181-190 of 320) with videos related to

Pageof 32
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1992
MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphomaC Marosi, R Heinz, G Steger, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2003
Gene expression profiling of colon cancer reveals a broad molecular repertoire in 5-fluorouracil resistanceW M Schmidt, M Kalipciyan, E Dornstauder, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administrationG G Steger, R M Mader, M P Djavanmard, et al.
Breast Care (Basel, Switzerland)|November 5, 2010
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast CancerSimon P Gampenrieder, Rupert Bartsch, Peter Matzneller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trialM Schmidinger, G Steger, C Wenzel, et al.
Anti-Cancer Drugs|June 3, 2005
Darbepoetin alpha as treatment for anemia in patients receiving chemotherapy: a single-center experienceRupert Bartsch, Catharina Wenzel, Ursula Sevelda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 1, 2014
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocolUrsula Pluschnig, Werner Haslik, Günther Bayer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 5, 2002
Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapyCatharina Wenzel, Gottfried J Locker, Manuela Schmidinger, et al.
British Journal of Cancer|March 6, 2003
Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancerR M Mader, C Schrolnberger, B Rizovski, et al.
Pageof 32

Showing results (181-190 of 320) with videos related to

Sort By:
Pageof 32
Journal of Cancer Research and Clinical Oncology|January 1, 1992
MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphomaC Marosi, R Heinz, G Steger, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2003
Gene expression profiling of colon cancer reveals a broad molecular repertoire in 5-fluorouracil resistanceW M Schmidt, M Kalipciyan, E Dornstauder, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administrationG G Steger, R M Mader, M P Djavanmard, et al.
Breast Care (Basel, Switzerland)|November 5, 2010
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast CancerSimon P Gampenrieder, Rupert Bartsch, Peter Matzneller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trialM Schmidinger, G Steger, C Wenzel, et al.
Anti-Cancer Drugs|June 3, 2005
Darbepoetin alpha as treatment for anemia in patients receiving chemotherapy: a single-center experienceRupert Bartsch, Catharina Wenzel, Ursula Sevelda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 1, 2014
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocolUrsula Pluschnig, Werner Haslik, Günther Bayer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 5, 2002
Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapyCatharina Wenzel, Gottfried J Locker, Manuela Schmidinger, et al.
British Journal of Cancer|March 6, 2003
Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancerR M Mader, C Schrolnberger, B Rizovski, et al.
Pageof 32